Author： Holloway Robert G Biglan Kevin M
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.2, 2002-02, pp. : 197-210
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Subcutaneous Apomorphine: An Evidence-Based Review of its Use in Parkinsons Disease
By Dirk Deleu
Drugs & Aging, Vol. 21, Iss. 11, 2004-01 ,pp. :
Implementing NICE clinical guidelines on Parkinson’s disease
By Ryton Beverly A Liddle B Jane
Clinical Medicine, Vol. 9, Iss. 5, 2009-10 ,pp. :
Rasagiline in the pharmacotherapy of Parkinson’s disease – a review
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. :
Gene therapy for Parkinson’s disease: review and update
Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. :